Integrity, transparency and discounts (ITD) for therapeutic products
The granting of advantages of any kind must not influence the prescribing, use or supply of prescription-only medicines. Any received discounts and rebates should be reported and passed on to the insurer or insured.
The new regulations on integrity, transparency and discounts have applied since 1 January 2020. The FOPH is responsible for enforcing these regulations.
You can find information on this subject on the following pages.